OKT3 first-dose reaction: Association with T cell subsets and cytokine release
- 1 January 1991
- journal article
- research article
- Published by Elsevier in Kidney International
- Vol. 39 (1), 141-148
- https://doi.org/10.1038/ki.1991.18
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Tumor Necrosis Factor and Disease Severity in Children with Falciparum MalariaNew England Journal of Medicine, 1989
- Muromonab CD3Drugs, 1989
- Systemic Reaction to the Anti–T-Cell Monoclonal Antibody OKT3 in Relation to Serum Levels of Tumor Necrosis Factor and Interferon-αNew England Journal of Medicine, 1989
- Interleukin 1 and tumor necrosis factor synergistically stimulate prostaglandin synthesis and phospholipase A2 release from rat renal mesangial cellsBiochemical and Biophysical Research Communications, 1989
- The role of cachectin/TNF in endotoxic shock and cachexiaImmunology Today, 1988
- Tumor necrosis factor stimulates prostaglandin production and cyclic AMP levels in rat cultured mesangial cellsFEBS Letters, 1988
- Detection of Circulating Tumor Necrosis Factor after Endotoxin AdministrationNew England Journal of Medicine, 1988
- Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic CancerNew England Journal of Medicine, 1985
- A Randomized Clinical Trial of OKT3 Monoclonal Antibody for Acute Rejection of Cadaveric Renal TransplantsNew England Journal of Medicine, 1985
- EFFECTS OF IN VIVO ADMINISTRATION OF MONOCLONAL ANTIBODIES SPECIFIC FOR HUMAN T CELL SUBPOPULATIONS ON THE IMMUNE SYSTEM IN A RHESUS MONKEY MODELTransplantation, 1983